Skip to main content
Erschienen in: Urolithiasis 6/2018

28.02.2018 | Original Paper

Uric acid stones increase the risk of chronic kidney disease

verfasst von: Ching-Chia Li, Tsu-Ming Chien, Wen-Jeng Wu, Chun-Nung Huang, Yii-Her Chou

Erschienen in: Urolithiasis | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to compare the clinical characteristics of uric acid stones and their potential risk for chronic kidney disease (CKD). A total of 401 patients (196 with uric acid stone and 205 without) were enrolled from our database of patients with urolithiasis. We analyzed the clinical demographic features, stone location, urine chemistries, and renal function. There was a significant difference (p < 0.001) between the two groups in terms of age, with the higher mean age in the uric acid group. Patients with uric acid stones had much lower pH of urine (p < 0.001) and higher serum uric acid level (p = 0.002). Notably, those with uric acid stones had worse eGFR than those with non-uric acid stones. Multivariate analysis confirmed that age over 60 years (ORs = 9.19; 95% CI 3.5–24.3), female sex (ORs = 4.01; 95% CI 1.8-9.0), hyperuricemia (ORs = 8.47; 95% CI 1.6–43.5), and uric acid stone (OR = 2.86; 95% CI 1.2–6.7) were the independent predictors of poor prognoses in CKD. Therefore, an association exists between uric acid stones and higher prevalence of CKD. Patients with uric acid stones may need close monitoring of renal function during follow-up.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Curhan GC (2007) Epidemiology of stone disease. Urol Clin N Am 34:287e93CrossRef Curhan GC (2007) Epidemiology of stone disease. Urol Clin N Am 34:287e93CrossRef
2.
Zurück zum Zitat Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309CrossRefPubMed Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309CrossRefPubMed
3.
Zurück zum Zitat Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245CrossRefPubMed Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245CrossRefPubMed
5.
Zurück zum Zitat Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033CrossRefPubMed Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033CrossRefPubMed
6.
Zurück zum Zitat Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed
7.
Zurück zum Zitat Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198:268–273CrossRefPubMed Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198:268–273CrossRefPubMed
8.
Zurück zum Zitat Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD (2016) Kidney function after the first kidney stone event. Mayo Clin Proc 91:1744–1752CrossRefPubMed Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD (2016) Kidney function after the first kidney stone event. Mayo Clin Proc 91:1744–1752CrossRefPubMed
9.
Zurück zum Zitat Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069–2075CrossRefPubMed Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069–2075CrossRefPubMed
10.
Zurück zum Zitat Chou YH, Li CC, Hsu H, Chang WC, Liu CC, Li WM, Ke HL, Lee MH, Liu ME, Pan SC, Wang HS (2011) Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 27:264–267CrossRefPubMed Chou YH, Li CC, Hsu H, Chang WC, Liu CC, Li WM, Ke HL, Lee MH, Liu ME, Pan SC, Wang HS (2011) Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 27:264–267CrossRefPubMed
11.
Zurück zum Zitat Worcester EM1, Parks JH, Evan AP (2006) Renal function in patients with nephrolithiasis. J Urol 176:600–603CrossRefPubMed Worcester EM1, Parks JH, Evan AP (2006) Renal function in patients with nephrolithiasis. J Urol 176:600–603CrossRefPubMed
12.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMed
13.
Zurück zum Zitat Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L (2015) Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int 89:185–192CrossRef Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L (2015) Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int 89:185–192CrossRef
14.
Zurück zum Zitat Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160CrossRefPubMed Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160CrossRefPubMed
15.
Zurück zum Zitat Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64:2204–2213CrossRefPubMed Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64:2204–2213CrossRefPubMed
16.
Zurück zum Zitat Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M (1980) Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol 238:F205–F209PubMed Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M (1980) Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol 238:F205–F209PubMed
18.
Zurück zum Zitat Klahr S, Morrissey J (2003) Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 87:105–112CrossRef Klahr S, Morrissey J (2003) Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 87:105–112CrossRef
19.
Zurück zum Zitat Kadlec AO, Greco KA, Fridirici ZC, Gerber D, Turk TM (2011) Effect of renal function on urinary mineral excretion and stone composition. Urology 78:744–747CrossRefPubMed Kadlec AO, Greco KA, Fridirici ZC, Gerber D, Turk TM (2011) Effect of renal function on urinary mineral excretion and stone composition. Urology 78:744–747CrossRefPubMed
20.
Zurück zum Zitat Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6:2364–2373CrossRefPubMed Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6:2364–2373CrossRefPubMed
21.
Zurück zum Zitat Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan ML, Ambrosioni E et al (2014) Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis 24:921–927CrossRefPubMed Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan ML, Ambrosioni E et al (2014) Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis 24:921–927CrossRefPubMed
22.
Zurück zum Zitat Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741CrossRef Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741CrossRef
23.
Zurück zum Zitat Bagby SP (2004) Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 15:2775–2791CrossRefPubMed Bagby SP (2004) Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 15:2775–2791CrossRefPubMed
24.
Zurück zum Zitat Schelling JR, Sedor JR (2004) The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J Am Soc Nephrol 15:2773–2774CrossRefPubMed Schelling JR, Sedor JR (2004) The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J Am Soc Nephrol 15:2773–2774CrossRefPubMed
25.
Zurück zum Zitat Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R, AMD-Annals Study Group (2017) Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One 12:e0176058CrossRefPubMed Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R, AMD-Annals Study Group (2017) Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One 12:e0176058CrossRefPubMed
26.
Zurück zum Zitat Chou YC, Kuan JC, Yang T, Chou WY, Hsieh PC, Bai CH, You SL, Chen CH, Wei CY, Sun CA (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28:457–462CrossRefPubMed Chou YC, Kuan JC, Yang T, Chou WY, Hsieh PC, Bai CH, You SL, Chen CH, Wei CY, Sun CA (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28:457–462CrossRefPubMed
27.
Zurück zum Zitat Sairam K, Scoffone CM, Alken P, Turna B, Sodha HS, Rioja J, Wolf JS Jr, de la Rosette JJ, CROES PCNL Study Group (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol 188:1195–1200CrossRefPubMed Sairam K, Scoffone CM, Alken P, Turna B, Sodha HS, Rioja J, Wolf JS Jr, de la Rosette JJ, CROES PCNL Study Group (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol 188:1195–1200CrossRefPubMed
28.
Zurück zum Zitat Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29: 715–734CrossRefPubMed Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29: 715–734CrossRefPubMed
Metadaten
Titel
Uric acid stones increase the risk of chronic kidney disease
verfasst von
Ching-Chia Li
Tsu-Ming Chien
Wen-Jeng Wu
Chun-Nung Huang
Yii-Her Chou
Publikationsdatum
28.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 6/2018
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1050-1

Weitere Artikel der Ausgabe 6/2018

Urolithiasis 6/2018 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.